Organization & Developments: Zosano

Parents

2022: On the heels of FDA rejection, tiny Zosano cuts about a third of its workforce as latest victim of the budget axe
Completed 5 drugs
Patch and applicator system for the delivery of therapeutic proteins, peptides and vaccines
Thin titanium screen with drug coated microprojections that allow drug to enter skin
Zosano is advancing a pipeline of drug candidates based on the ZP Patch Technology – a proprietary transdermal delivery technology capable of delivering peptides, proteins, small molecules and vaccines by permeating the skin’s outer layer
Zosano’s patent portfolio is both deep and broad with more than 19 patent families in the US, 12 in the EU, and 20 patent applications pending.